Citations

Clear

112 citation(s) found for "Nguyen, Thuy".

P2‐079: Assessment of The Known and Candidate Alzheimer's Disease Genes in African‐Americans
N’Songo, Aurelie, Carrasquillo, Minerva M. , Wang, Xue , Nguyen, Thuy , Asmann, Yan W. , Younkin, Steven G. , Graff‐Radford, Neill R. , Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Burgess, Jeremy D.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_13 | Pages: No page available

10.1016/j.jalz.2016.06.1284 Get It

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
Group, Australian Ovarian Cancer Study, Study, Australian Cancer, Johnatty, Sharon E. , Lu, Yi , Beesley, Jonathan, Gao, Bo , Kalimutho, Murugan , Henderson, Michelle J. , Russell, Amanda J. , Kar, Siddhartha , Chen, Xiaoqing, Hillman, Kristine M. , Kaufmann, Susanne, Sivakumaran, Haran , O’Reilly, Martin, Wang, Chen , Korbie, Darren , Lambrechts, Diether , Despierre, Evelyn, Nieuwenhuysen, Els Van , Lambrechts, Sandrina, Vergote, Ignace , Lester, Jenny, Oršulić, Sandra , Walsh, Christine M. , Fasching, Peter A. , Beckmann, Matthias W. , Ekici, Arif B. , Hein, Alexander , Matsuo, Keitaro , Hosono, Satoyo , Pisterer, Jacobus, Hillemanns, Peter , Nakanishi, Toru , Yatabe, Yasushi , Goodman, Marc T. , Lurie, Galina, Matsuno, Rayna K., Thompson, Pamela J., Bean, Yukie T., Heitz, Florian , Harter, Philipp , Schwaab, Ira, Høgdall, Estrid , Jensen, Allan , Høgdall, Claus , Lundvall, Lene, Engelholm, Svend Aage, Brown, Bob, Flanagan, James M. , Metcalf, Michelle, Sellers, Thomas A. , Cunningham, Julie M. , Schildkraut, Joellen M. , Iversen, Ed , Weber, Rachel Palmieri , Brennan, Donal J. , Harnett, Paul R. , Haber, Michelle , Goode, Ellen L. , Lee, Jason S. , Khanna, Kum Kum , Meyer, Kerstin B. , Chenevix‐Trench, Georgia , DeFazio, Anna , Edwards, Stacey L. , MacGregor, Stuart , Brown, Robert , Lambrechts, Diether , Cunningham, Julie, Fazio, Anna de , French, Juliet D. , Group, Australian Ovarian Cancer Study, Study, Australian Cancer, Beesley, Jonathan, Chen, Xiaoqing, Karlan, Beth Y. , Pejovic, Tanja B. , Bois, Andreas du , Kjær, Susanne K. , Brown, Bob, Siddiqui, Nadeem , Fridley, Brooke L. , Berchuck, Andrew , Pharoah, Paul D.P. , Norris, Murray D , Lambrechts, Diether , Hein, Alexander , Hillemanns, Peter , Jensen, Allan , Haber, Michelle , Wang, Chen , Brown, Robert , Matsuo, Keitaro , Flanagan, James M , Heitz, Florian , Lambrechts, Diether , Ekici, Arif B , Lu, Yi , MacGregor, Stuart , Chenevix-Trench, Georgia , Høgdall, Estrid , Høgdall, Claus K , Kar, Siddhartha , Harnett, Paul R , Goodman, Marc T

Mayo Clinic

Oncotarget | January 31, 2016 | Volume: 7 | Issue: 6 | Pages: 6353-6368

10.18632/oncotarget.7047 | PMID 26840454 Get It

P1‐060: Neurox associations with Alzheimer's disease in african americans
N’Songo, Aurelie, Carrasquillo, Minerva M. , Barber, Imelda, Nguyen, Thuy , Bisceglio, Gina, Younkin, Steven G., Taner, Nilüfer, Carrasquillo, Minerva M. , Ma, Li , Graff, Caroline , Morgan, Kevin

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_8 | Pages: No page available

10.1016/j.jalz.2015.06.257 Get It

P1‐049: Exploiting blood transcriptome for gene and pathway identification in Alzheimer's disease
Allen, Mariet , Wang, Xue , Serie, Daniel, Strickland, Samantha L. , Nguyen, Thuy , Malphrus, Kimberly G., Lincoln, Sarah, Carrasquillo, Minerva M. , Schellenberg, Gerard D. , Lowe, Val J. , Younkin, Steven G. , Asmann, Yan W. , Petersen, Ronald C. , Taner, Nilüfer, Burgess, Jeremy D. , Carrasquillo, Minerva M. , Crook, Julia E. , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2015.06.245 Get It

P2‐015: Exploring alternative splicing and gene expression of load candidate genes in blood
Allen, Mariet , Kachadoorian, Michaela, Nguyen, Thuy , Malphrus, Kimberly G., Lincoln, Sarah, Carrasquillo, Minerva M. , Schellenberg, Gerard D. , Lowe, Val J. , Younkin, Steven G. , Petersen, Ronald C. , Taner, Nilüfer, Burgess, Jeremy D. , Carrasquillo, Minerva M. , Knopman, David S. , Jack, Clifford R. , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2015.06.551 Get It

Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma
Nguyen, Thuy , Phillips, Daniel , Jain, Dhanpat , Wu, Tsung‐Teh, Yeh, Matthew M., Kakar, Sanjay , Torbenson, Michael , Kakar, Sanjay

Mayo Clinic

Archives of Pathology & Laboratory Medicine | July 31, 2015 | Volume: 139 | Issue: 8 | Pages: 1028-1034

10.5858/arpa.2014-0479-oa | PMID 26230595 Get It

Context Several immunohistochemical markers are available to establish the diagnosis of hepatocellular carcinoma. Judicious selection is essential to achieve a reliable diagnosis in limited tissue provided by liver biopsy. Objective To compare the efficacy of 5 hepatocellular markers for the diagnosis of hepatocellular carcinoma across various levels of differentiations. Design Immunohistochemistry for hepatocyte paraffin antigen 1 (Hep Par 1), polyclonal carcinoembryonic antigen (CEA), glypican-3, arginase-1, and bile salt export pump transporter was performed in 79 hepatocellular carcinomas, yielding 93 observations (13 well-differentiated [14%], 41 moderately differentiated [44%], and 39 poorly differentiated [42%] tumors). Results Arginase-1 and Hep Par 1 had the highest sensitivity for well-differentiated hepatocellular carcinoma, whereas arginase-1 and glypican-3 had the highest sensitivity for poorly differentiated hepatocellular carcinoma. When staining of more than 50% of the tumor was considered a positive result, arginase-1 remained the most sensitive marker for all differentiations, whereas sensitivity for Hep Par 1 in poorly differentiated hepatocellular carcinoma dropped to 30% and that of glypican-3 in well-differentiated hepatocellular carcinoma was 15%. The addition of Hep Par 1 and/or polyclonal CEA to arginase-1 did not lead to an increase in sensitivity for any differentiation. The combined use of arginase-1 and glypican-3 yielded 100% sensitivity for poorly differentiated hepatocellular carcinoma. Conclusion Arginase-1 was the most sensitive marker in all differentiations of hepatocellular carcinoma. Glypican-3 had high sensitivity for poorly differentiated cases and its combined use with arginase-1 enabled identification of nearly all cases of poorly differentiated hepatocellular carcinoma. Although bile salt export pump transporter has good overall sensitivity, it has a limited role in establishing hepatocellular differentiation when added to a panel of arginase-1 with either glypican-3 or Hep Par 1.